Pfizer Inc

WHO gives ‘emergency validation’ to Pfizer-BioNTech corona vaccine, calls for equitable global access

The WHO, together with the GAVI Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI), are spearheading a global effort called COVAX to distribute vaccines to low- and middle-income countries.

Coronavirus Vaccine Updates: दुनिया की पहली COVID-19 वैक्सीन मंजूर! UK में शुरू होगा Pfizer-BioNTech वैक्सीन का इस्तेमाल

Pfizer-BioNTech की वैक्सीन कोविड19 से रोकथाम में 95 फीसदी तक सुरक्षित पाई गई है.

COVID19 Vaccine Updates: फाइजर की वैक्सीन के फेज-3 ट्रायल खत्म, कोरोनावायरस की रोकथाम में 95% कारगर साबित

Market Highlights: Sensex ends 680 pts higher, Nifty closes at 12,631; financials zoom, pharma, IT stocks bleed

Share Market News Today | Sensex, Nifty, Share Prices Highlights: Sensex and Nifty surged yet again on Tuesday, setting fresh all-time highs. Benchmark indices closed near their highs after rallying for the seventh day straig

COVID-19 Vaccine Updates: Pfizer, BioNTech की वैक्सीन 90% कारगर, आने वाले हफ्तों में जारी होंगे और आंकड़े

फाइजर के चेयरमैन व सीईओ अल्बर्ट बॉरला ने कहा कि यह विज्ञान और मानवता के लिए एक बड़ा दिन

Pfizer share price surges 13%. Coronavirus cure found? Here’s what company claims

Share price of drug-maker Pfizer Limited surged 13 per cent on Tuesday morning after reports claimed that the parent company of Pfizer, has identified some antiviral compounds with potential as Coronavirus treatments.

Obama’s inversion curbs kill Pfizer’s $160 billion Allergan deal

US drug maker Pfizer Inc's agreed on Tuesday to terminate its $160 billion agreement to acquire Botox maker Allergan Plc, in a major victory to US President Barack Obama's drive to stop tax-dodging corporate mergers.

India rejects patent on Pfizer’s arthritis drug tofacitinib

India has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country.

Pfizer’s stop-smoking drug Chantix not linked to depression or heart risks

Pfizer's stop-smoking drug Chantix does not raise risks of heart attack or depression, contrary to previous reports, and should be recommended to more smokers wanting to quit, scientists said on Monday.

Pfizer, Bristol revive cancer drugs that rev up immune system

Some of the most heralded new cancer drugs fight the disease by removing brakes on the immune system. Now a few leading drugmakers are paying attention to a second, opposing force: medicines that accelerate the immune system'

Britain raps Pfizer over inflated epilepsy drug prices

Britain's competition watchdog alleged on Thursday that U.S. drugmaker Pfizer and Flynn Pharma had breached competition law by ramping up the cost of an epilepsy drug used by more than 50,000 British patients.

Wyeth denied patent for cancer drug

The patent office order came in response to a pre-grant opposition filed by Fresenius Kabi Oncology, which alleged that the ‘invention’ was publicly known in India before the priority date of Wyeth’s claim

Lupin gets US FDA approval for generic Celebrex capsules

Lupin’s Celecoxib capsules are the AB-rated generic equivalents of GD Searle LLC ‘s Celebrex capsules